Hongchang International Co., Ltd. Files Annual Report on Form 10-K
Ticker: HCIL · Form: 10-K · Filed: Apr 1, 2024 · CIK: 1086303
| Field | Detail |
|---|---|
| Company | Hongchang International Co., Ltd (HCIL) |
| Form Type | 10-K |
| Filed Date | Apr 1, 2024 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001, $1, $335,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, Annual Report, Hongchang International, SEC Filing, Financials
TL;DR
<b>Hongchang International Co., Ltd. has filed its 2023 annual report on Form 10-K, confirming compliance with filing requirements.</b>
AI Summary
Hongchang International Co., Ltd (HCIL) filed a Annual Report (10-K) with the SEC on April 1, 2024. Hongchang International Co., Ltd. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023. The company is incorporated in Nevada and its principal executive offices are located in Fuqing City, Fujian Province, China. The filing indicates the company is not a well-known seasoned issuer and is not required to file reports under Section 13 or 15(d) of the Act. Hongchang International Co., Ltd. has filed all required reports for the preceding 12 months and has been subject to such filing requirements for the past 90 days. The company has submitted electronically every Interactive Data File required by Rule 405 of Regulation S-T during the preceding 12 months.
Why It Matters
For investors and stakeholders tracking Hongchang International Co., Ltd, this filing contains several important signals. This 10-K filing provides a comprehensive overview of the company's financial performance and operational status for the fiscal year 2023. As a smaller reporting company, this filing is crucial for investors to assess the company's financial health and future prospects.
Risk Assessment
Risk Level: low — Hongchang International Co., Ltd shows low risk based on this filing. The risk is low as the filing confirms the company has met all its reporting obligations for the past year and is not subject to any unusual reporting requirements.
Analyst Insight
Review the full 10-K filing to understand Hongchang International's financial performance and operational details for fiscal year 2023.
Key Numbers
- 2023-12-31 — Fiscal Year End (The period covered by the annual report.)
- 000-26731 — Commission File Number (SEC file number for the company.)
- 87-0627910 — IRS Number (Company's IRS Employer Identification Number.)
Key Players & Entities
- Hongchang International Co., Ltd. (company) — Registrant name
- Nevada (location) — State of incorporation
- Fuqing City, Fujian Province, China (location) — Principal executive offices address
- December 31, 2023 (date) — Fiscal year end
- 2023 (date) — Fiscal year
- 1934 Act (regulation) — SEC Act
- Rule 405 of Regulation S-T (regulation) — Interactive Data File submission requirement
FAQ
When did Hongchang International Co., Ltd file this 10-K?
Hongchang International Co., Ltd filed this Annual Report (10-K) with the SEC on April 1, 2024.
What is a 10-K filing?
A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by Hongchang International Co., Ltd (HCIL).
Where can I read the original 10-K filing from Hongchang International Co., Ltd?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Hongchang International Co., Ltd.
What are the key takeaways from Hongchang International Co., Ltd's 10-K?
Hongchang International Co., Ltd filed this 10-K on April 1, 2024. Key takeaways: Hongchang International Co., Ltd. filed its annual report on Form 10-K for the fiscal year ended December 31, 2023.. The company is incorporated in Nevada and its principal executive offices are located in Fuqing City, Fujian Province, China.. The filing indicates the company is not a well-known seasoned issuer and is not required to file reports under Section 13 or 15(d) of the Act..
Is Hongchang International Co., Ltd a risky investment based on this filing?
Based on this 10-K, Hongchang International Co., Ltd presents a relatively low-risk profile. The risk is low as the filing confirms the company has met all its reporting obligations for the past year and is not subject to any unusual reporting requirements.
What should investors do after reading Hongchang International Co., Ltd's 10-K?
Review the full 10-K filing to understand Hongchang International's financial performance and operational details for fiscal year 2023. The overall sentiment from this filing is neutral.
How does Hongchang International Co., Ltd compare to its industry peers?
The filing is a standard annual report (10-K) for a publicly traded company in the United States, adhering to SEC regulations.
Are there regulatory concerns for Hongchang International Co., Ltd?
The company is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934.
Industry Context
The filing is a standard annual report (10-K) for a publicly traded company in the United States, adhering to SEC regulations.
Regulatory Implications
The company is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934.
What Investors Should Do
- Review the full 10-K document for detailed financial statements and management's discussion and analysis.
- Assess the company's compliance with SEC filing requirements.
- Identify any specific operational or financial disclosures made in the report.
Key Dates
- 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the 10-K filing.
- 2024-04-01: Filing Date — Date the 10-K report was filed with the SEC.
Year-Over-Year Comparison
This filing represents the company's annual report for the fiscal year 2023, following previous filings as required by the SEC.
Filing Stats: 4,611 words · 18 min read · ~15 pages · Grade level 13.7 · Accepted 2024-04-01 16:34:53
Key Financial Figures
- $0.001 — CTION 12(g) OF THE ACT: Common Stock, $0.001 par value per share (Title of Class)
- $1 — ing sales price for the common stock of $1.78, as reported on the OTC Pink Market,
- $335,000 — ller for an aggregate purchase price of $335,000 ("Share Purchase"). As a result of the
Filing Documents
- ea0201030-10k_hong.htm (10-K) — 933KB
- ea020103001ex14-1_hongchang.htm (EX-14.1) — 37KB
- ea020103001ex19-1_hongchang.htm (EX-19.1) — 63KB
- ea020103001ex21-1_hongchang.htm (EX-21.1) — 5KB
- ea020103001ex31-1_hongchang.htm (EX-31.1) — 8KB
- ea020103001ex31-2_hongchang.htm (EX-31.2) — 8KB
- ea020103001ex32-1_hongchang.htm (EX-32.1) — 4KB
- ea020103001ex32-2_hongchang.htm (EX-32.2) — 4KB
- image_001.jpg (GRAPHIC) — 194KB
- image_002.jpg (GRAPHIC) — 8KB
- image_003.jpg (GRAPHIC) — 5KB
- 0001213900-24-028792.txt ( ) — 5893KB
- hcil-20231231.xsd (EX-101.SCH) — 65KB
- hcil-20231231_cal.xml (EX-101.CAL) — 41KB
- hcil-20231231_def.xml (EX-101.DEF) — 244KB
- hcil-20231231_lab.xml (EX-101.LAB) — 404KB
- hcil-20231231_pre.xml (EX-101.PRE) — 236KB
- ea0201030-10k_hong_htm.xml (XML) — 618KB
BUSINESS
BUSINESS 1 ITEM 1A. RISK FACTORS 7 ITEM 1B. UNRESOLVED STAFF COMMENTS 10 ITEM 1C. CYBERSECURITY 10 ITEM 2.
PROPERTIES
PROPERTIES 11 ITEM 3. LEGAL PROCEEDINGS 11 ITEM 4. MINE SAFETY DISCLOSURES 11 PART II ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 12 ITEM 6. [RESERVED] 13 ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 14 ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 18 ITEM 8. FINANCIAL 18 ITEM 9. CHANGES OF INDEPENDENT CERTIFYING ACCOUNTANT 19 ITEM 9A. CONTROLS AND PROCEDURES 19 ITEM 9B. OTHER INFORMATION 19 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections. 19 PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 20 ITEM 11. EXECUTIVE COMPENSATION 23 ITEM 12. SECURITY 24 ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE 25 ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES 25 PART IV ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 26 ITEM 16. FORM 10-K SUMMARY 27
SIGNATURES
SIGNATURES 28 i PART I Unless otherwise indicated, all share amounts and per share amounts in this Report have been presented giving effect to a 1-for-464 reverse split that became effective on April 11, 2018, a 100-for-1 forward stock split that became effective on September 11, 2018, and a 1-for-10 reverse stock split effective on August 14, 2023. Unless the context requires otherwise, references in this Annual Report on Form 10-K to the "Company" or "our Company" refer to Hongchang International Co., Ltd (formerly known as Heyu Biological Technology Corporation), a Nevada company; "we," "us," and "our" refer to Hongchang International Co., Ltd and its subsidiaries, unless the context otherwise indicates. ITEM 1. BUSINESS The Company is a holding company incorporated in the State of Nevada and not a Chinese operating company. As a holding company with no material operations of our own, we conduct our operations and operate our business in China through our subsidiaries. Holders of our stock hold equity interest in Hongchang International Co., Ltd, a Nevada holding company with business operations in China and therefore, may never hold equity interests directly in our Chinese operating entities. The Company holds equity interests in its PRC subsidiaries through its subsidiaries incorporated in British Virgin Islands and Hong Kong. As we have a direct equity ownership structure, we do not have any agreement or contract between our Company and any of its subsidiaries that is typically seen in a variable interest entity structure. There are significant legal and operational risks associated with conducting a substantial portion of our operations in mainland China, including, the changes in the legal, political, and economic policies of the Chinese government, may materially and adversely affect our business, financial condition, results of operations, and the market price of our shares. Any such changes could significantly limit or completely hinder ou